News

New insights into how cancer spreads prompt rethink of metastasis care
A McGill University-led research collaboration has achieved a breakthrough in understanding how cancer spreads. A clinical ...
The American Journal of Managed Care7h
Comprehensive Molecular Testing in Patients With Ovarian Cancer
A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a ...
The American Journal of Managed Care7h
Emerging Molecular Biomarkers in Ovarian Cancer
A panelist discusses how multiple molecular biomarkers beyond BRCA and homologous recombination deficiency (HRD) testing are ...
Cancer Therapy Advisor16h
CDK2 Inhibitor Gets Fast Track Status for CCNE1-Amplified Ovarian Cancer
The FDA has granted fast track designation to INX-315 for the treatment of CCNE1-amplified, platinum-resistant/refractory ovarian cancer.